Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.

[1]  Jeffrey N. Browndyke,et al.  Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial , 2017, JAMA.

[2]  Jeroen J. Bax,et al.  Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke , 2017, European heart journal.

[3]  J. Tijssen,et al.  Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study , 2017, American heart journal.

[4]  G. Dangas,et al.  Cerebral Embolic Protection During TAVR: A Clinical Event Meta-Analysis. , 2017, Journal of the American College of Cardiology.

[5]  R. Virmani,et al.  Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement. , 2017, Journal of the American College of Cardiology.

[6]  V. Rajagopal,et al.  Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials , 2016, Circulation. Cardiovascular interventions.

[7]  M. Mack,et al.  Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves) , 2016, Circulation. Cardiovascular interventions.

[8]  K. Takagi,et al.  Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding , 2016, Heart.

[9]  C. Lücke,et al.  Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial. , 2016, JAMA.

[10]  J. Leipsic,et al.  Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. , 2016, European heart journal.

[11]  H. Eggebrecht,et al.  Incidence and Clinical Impact of Stroke Complicating Transcatheter Aortic Valve Implantation: Results From the German TAVI Registry , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  J. Leipsic,et al.  Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.

[13]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[14]  P. Stella,et al.  Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation. , 2016, American heart journal.

[15]  Deepak L. Bhatt,et al.  Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. , 2015, The New England journal of medicine.

[16]  P. Wenaweser,et al.  The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients. , 2015, Journal of the American College of Cardiology.

[17]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[18]  J. Mega,et al.  Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. , 2013, Journal of the American College of Cardiology.

[19]  J. Spertus,et al.  Use of the Kansas City Cardiomyopathy Questionnaire for Monitoring Health Status in Patients With Aortic Stenosis , 2013, Circulation. Heart failure.

[20]  Martin Schumacher,et al.  Competing Risks and Multistate Models , 2012, Clinical Cancer Research.

[21]  Martin B Leon,et al.  Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). , 2012, Journal of the American College of Cardiology.

[22]  A. Kirtane,et al.  Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. , 2011, Journal of the American College of Cardiology.

[23]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[24]  H. Schaff.  Transcatheter aortic-valve implantation--at what price? , 2011, The New England journal of medicine.

[25]  B. Carabello.  Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.

[26]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[27]  D. Rubin.  The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials , 2007, Statistics in medicine.

[28]  M. Pintilie.  Competing Risks: A Practical Perspective , 2006 .

[29]  D. Rubin,et al.  Combining Propensity Score Matching with Additional Adjustments for Prognostic Covariates , 2000 .

[30]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.

[31]  F. Coolen,et al.  Statistical Models Based on Counting Processes. , 1996 .

[32]  Leo Breiman,et al.  Bagging Predictors , 1996, Machine Learning.

[33]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[34]  D. Rubin.  Multiple imputation for nonresponse in surveys , 1989 .

[35]  Malcolm E. Turner,et al.  The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .

[36]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[37]  Put Into Perspective for the Practicing Clinician 2243 Stroke After Aortic Valve Surgery : Results From a Prospective Cohort , 2014 .

[38]  M. Mack,et al.  ACQUIRED CARDIOVASCULAR DISEASE Transcatheter ( TAVR ) versus surgical ( AVR ) aortic valve replacement : Occurrence , hazard , risk factors , and consequences of neurologic events in the PARTNER trial , 2012 .

[39]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .